Toorop AA, Wessels MH, Boonkamp L, Gelissen LM, et al. Serum neurofilament light and glial fibrillary acidic protein levels are not associated with wearing-off symptoms in natalizumab-treated multiple sclerosis patients. Mult Scler 2024 Nov 4:13524585241293940. doi: 10.1177/13524585241293940.
PMID: 39494701